# Trial of THEO-260 in Ovarian Cancer Patients

> **NCT06618235** · PHASE1,PHASE2 · RECRUITING · sponsor: **Theolytics Limited** · enrollment: 44 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** THEO-260

## Key facts

- **NCT ID:** NCT06618235
- **Lead sponsor:** Theolytics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-24
- **Primary completion:** 2028-06
- **Final completion:** 2028-06
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618235, "Trial of THEO-260 in Ovarian Cancer Patients". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06618235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*